More evidence for worse COVID-19 outcomes in people with HIV
Authors:
- 13 October 2021
- journal article
- editorial
- Published by Elsevier in The Lancet HIV
- Vol. 8 (11) , e661-e662
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) dataThe Lancet HIV, 2021
- Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort studyThe Lancet HIV, 2021
- Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trialeClinicalMedicine, 2021
- Excess deaths associated with covid-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countriesBMJ, 2021
- Risk of adverse coronavirus disease 2019 outcomes for people living with HIVAIDS, 2021
- COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York StateJAMA Network Open, 2021
- Immune deficiency is a risk factor for severe COVID‐19 in people living with HIVHIV Medicine, 2020
- Factors associated with COVID-19-related death using OpenSAFELYNature, 2020